BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
68.00
0.00 (0.00%)
At close: Feb 6, 2026

TYO:4594 Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2018FY 2017
Period Ending
Sep '25 Mar '25 Mar '24 Mar '18 Mar '17
Net Income
-1,075-1,151-1,168-1,573-1,116
Depreciation & Amortization
--0.47341
Asset Writedown & Restructuring Costs
1.961.377.25--
Other Operating Activities
-65.93-103.060.7-313
Change in Accounts Receivable
0.03-1.140.05-2251
Change in Inventory
---14-6
Change in Accounts Payable
-0.010.02-0.06-13-41
Change in Other Net Operating Assets
-181.913.612.82-67-9
Operating Cash Flow
-1,321-1,250-1,157-1,591-1,067
Capital Expenditures
-1.96-1.37-6.19-108-97
Cash Acquisitions
----7
Sale (Purchase) of Intangibles
---1.45-3-6
Investing Cash Flow
-3.3-1.37-7.65-111-96
Long-Term Debt Issued
-500500--
Long-Term Debt Repaid
--587.5-387.5--
Net Debt Issued (Repaid)
-325-87.5112.5--
Issuance of Common Stock
1,3631,093578.463,2813,559
Repurchase of Common Stock
-0-1.04---
Other Financing Activities
-0-00--
Financing Cash Flow
1,0381,005690.963,2813,559
Miscellaneous Cash Flow Adjustments
-0---1-1
Net Cash Flow
-286.8-246.89-473.611,5782,395
Free Cash Flow
-1,323-1,252-1,163-1,699-1,164
Free Cash Flow Margin
-119186.22%-110479.17%-1615436.11%-479.94%-220.04%
Free Cash Flow Per Share
-13.97-15.36-18.13-44.44-34.22
Cash Income Tax Paid
1.91.91.932
Levered Free Cash Flow
--836.04--1,029-
Unlevered Free Cash Flow
--836.04--1,029-
Change in Working Capital
-181.882.492.81-88-5
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.